Insider at

04

Insider transactions

05
2 buys (P) 0 sells (S) Net: $103,604 + 4 non-open-market transactions below Avg return of open purchases vs now: 69.5% last 12 months, based on the transactions shown below

Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted

4 other filings hidden
DateTickerCodeSharesPriceValue Owned afterΔ ownA/Dvs now
March 17, 2026 HBIO P 8,475 $4.85 $41,104 32,000 Direct +36.03% Acquired 72.0% (price as of 2026-10-02)
March 16, 2026 HBIO P 12,525 $4.99 $62,500 23,525 Direct +113.86% Acquired 67.1% (price as of 2026-10-02)

P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding

Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.

Initial ownership (Form 3) 2 holdings

07

Securities held when first becoming an insider, per SEC Form 3.

DateTickerSecuritySharesOwnership
Dec. 30, 2025 HBIO Warrant (right to buy)→ Common Stock (150,000) 150,000 Indirect
Dec. 30, 2025 HBIO Warrant (right to buy)→ Common Stock (600,000) 600,000 Indirect